These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 10181051)

  • 21. Distribution of blood derivatives by registered blood establishments that qualify as health care entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; delay of applicability date. Final rule; delay of applicability date.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Nov; 71(218):66108-9. PubMed ID: 17099971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicare program; prospective payment system for long-term care hospitals RY 2009: annual payment rate updates, policy changes, and clarifications; and electronic submission of cost reports: revision to effective date of cost reporting period. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 May; 73(91):26787-874. PubMed ID: 18567174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Final notice regarding section 602 of the Veterans Health Care Act of 1992 duplicate discounts and rebates on drug purchases--HRSA. Final notice.
    Fed Regist; 1993 Jun; 58(119):34058-9. PubMed ID: 10126861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2003 and inclusion of registered nurses in the personnel provision of the critical access hospital emergency services requirement for frontier areas and remote locations. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2002 Dec; 67(251):79965-80184. PubMed ID: 12510665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicare program: changes to the hospital outpatient prospective payment system and CY 2008 payment rates, the ambulatory surgical center payment system and CY 2008 payment rates, the hospital inpatient prospective payment system and FY 2008 payment rates; and payments for graduate medical education for affiliated teaching hospitals in certain emergency situations Medicare and Medicaid programs: hospital conditions of participation; necessary provider designations of critical access hospitals. Interim and final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Nov; 72(227):66579-7226. PubMed ID: 18044033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. US organ donation breakthrough collaborative increases organ donation.
    Shafer TJ; Wagner D; Chessare J; Schall MW; McBride V; Zampiello FA; Perdue J; O'Connor K; Lin MJ; Burdick J
    Crit Care Nurs Q; 2008; 31(3):190-210. PubMed ID: 18574367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescription Drug Marketing Act Pedigree Requirements; effective date and compliance policy guide; request for comment. Final rule; announcement of effective date; notice of availability; request for comment.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jun; 71(114):34249-51. PubMed ID: 16795943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human tissue intended for transplantation--FDA. Interim rule; opportunity for public comment.
    Fed Regist; 1993 Dec; 58(238):65514-21. PubMed ID: 10131341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Privacy Act of 1974; system of records--PHS. Waiver of advance notice period for a new system of records.
    Fed Regist; 1983 Aug; 48(169):39299-302. PubMed ID: 10262089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abortions and related medical services in federally assisted programs of the Public Health Service: final rule.
    Fed Regist; 1979 Feb; 44(24):6716-8. PubMed ID: 10297329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicaid program; time limitation on record keeping requirements under the drug rebate program. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2004 Jan; 69(3):508-14. PubMed ID: 14968795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicare program; update of ratesetting methodology, payment rates, payment policies, and the list of covered procedures for ambulatory surgical centers effective October 1, 1998; reopening of comment period and delay in adoption of the proposed rule as final--HCFA. Notice of reopening of comment period for proposed rule and delay in adoption of provisions of the proposed rule as final.
    Fed Regist; 1998 Oct; 63(190):52663-5. PubMed ID: 10185818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicare program; home health prospective payment system refinement and rate update for calendar year 2008. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Aug; 72(167):49761-945. PubMed ID: 17886396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicare and Medicaid programs; physicians' referrals to health care entities with which they have financial relationships. Health Care Financing Administration (HCFA), HHS. Final rule with comment period.
    Fed Regist; 2001 Jan; 66(3):856-965. PubMed ID: 11503745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medicare and Medicaid programs; requirements for physician incentive plans in prepaid health care organizations--HCFA. Final rule correction; notice of changes in compliance dates, with comment period.
    Fed Regist; 1996 Sep; 61(171):46384-5. PubMed ID: 10184595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medicare program; prospective payment system for hospital outpatient services. Health Care Financing Administration (HCFA), HHS. Interim final rule with comment period.
    Fed Regist; 2000 Nov; 65(219):67798-8020. PubMed ID: 11503707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human drugs and biologics; determination that informed consent is NOT feasible or is contrary to the best interests of recipients; revocation of 1990 interim final rule; establishment of new interim final rule. Food and Drug Administration, HHS. Interim final rule; opportunity for public comment.
    Fed Regist; 1999 Oct; 64(192):54180-9. PubMed ID: 11010702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health Resources and Services Administration. Final eligibility criteria, preferences, and priorities for scholarships for disadvantaged students.
    Fed Regist; 1999 Sep; 64(169):47849-53. PubMed ID: 10558607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date. Final rule; delay of effective date.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Feb; 69(35):8105-7. PubMed ID: 14997866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE Dental Program. Office of the Secretary, DoD. Final rule.
    Fed Regist; 2001 Mar; 66(41):12855-71. PubMed ID: 11503866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.